Whole-body glucose turnover was measured by determining the specific activity of glucose in the steady-state plasma using a scintillation counter. Hepatic glucose production was assumed to represent ∼90% of the measured whole-body glucose turnover based on our previously published data (7 (
link)). Liver-specific metabolic flux rates were calculated using a combined NMR-LC-MS/MS method. We corrected for the natural abundance of each metabolite included in the flux calculations, measuring all possible enrichments (for instance, m+0, m+1, m+2, m+3, and m+4 for malate) and correcting the measured peak areas to account for the fact that once a carbon is labeled it can no longer contribute to the natural abundance (10 (
link)). Samples were prepared for NMR by homogenizing 2–3 g of liver in 5 volumes of 7% perchloric acid. The pH of the samples was adjusted to 6.8–7.3 using 30% potassium hydroxide and 7% perchloric acid as necessary, and the samples were centrifuged at 4000 ×
g for 10 min. The supernatant was frozen in liquid N
2 and lyophilized.
13C NMR analysis was performed as described by Befroy
et al. (6 (
link)). Total glucose and alanine enrichment was measured by GC/MS and glutamate by LC-MS/MS, with
13C NMR used to algebraically divide the total enrichment to determine the enrichment of each carbon of these metabolites.
We calculated the [2-
13C]malate enrichment by relating the positional enrichments of malate to those measured in glutamate assuming (and validating) full equilibration across fumarase as shown in
Equations 1 and
2.
For calculation of the liver-specific metabolic flux ratio
VPyr-Cyc/
VMito = (
VPK +
VME, out)/(
VPC +
VME, in+
VPDH), we used our previously published isotopic labeling model (6 (
link), 7 (
link)) extended using a mass isotopomer multiordinate spectral analysis approach to take into account
VPK and unlabeled mass entry from propionate at the succinyl-CoA step of the TCA cycle (10 (
link)). Here,
VME, out refers to ME flux in the direction of pyruvate synthesis;
VME, in refers to the reverse reaction of pyruvate into malate, and
VLDH refers to pyruvate synthesis via LDH. With these fluxes taken into account, we can describe the steady-state mass balance at pyruvate with
Equation 3,
and isotope balance at [2-
13C]pyruvate with
Equation 4,
Because the positional enrichments of pyruvate and PEP cannot be measured reliably using our NMR-LC-MS/MS techniques, we use the following label substitutions shown in
Equations 5 and
6,
Substituting
Equations 5 and
6 into
Equation 4 and rearranging, we derive
Equation 7,
By separating out like terms, we get
Equation 8,
where
VPDH denotes flux through pyruvate dehydrogenase;
VCS denotes flux through citrate synthase;
VPK denotes flux through pyruvate kinase;
VME, out denotes flux through malic enzyme from malate to pyruvate;
VME, in denotes flux through malic enzyme from pyruvate to malate; and
VPC denotes flux through pyruvate carboxylase. Additional fluxes shown in the complete flux diagram in
Fig. 1 are
VGNG OAA gluconeogenesis from oxaloacetate,
VGNG total gluconeogenesis, and
Vprop the rate of propionate entry into the TCA cycle.
VPDH/
VCS was measured using the ratio [4-
13C]glutamate/[3-
13C]alanine, as described by Alves
et al. (11 (
link)).